Chief Development Officer Christopher Yea sold $63K of KalVista Pharmaceuticals, Inc.

Sold$63,158

$26.78Price

2,358Shares

−1%Stake

What KALV did after the filing

Prices for KALV after this filing aren't in yet.

Traded Fri, May 22. Filed Tue, May 26, 7:33 PM ET, after the close. Not investment advice.